Ono Pharmaceutical Co., Ltd. · TSE:4528

Ono Pharmaceutical — ESG Presentation (March 2024)

47 slides from Ono Pharmaceutical's sustainability presentation, Mar 26, 2024

  1. Slide 1: ESG Meeting

    ESG Meeting March 26, 2024 ono ONO PHARMA

  2. Slide 2: Agenda

    Agenda Sustainable Management / Materiality(16:00-16:10) President, Representative Director, and CEO Gyo Sagara Corporate Governance(16:10-16:25) Member of the Board of Directors, Outside Director Masao Nomura Expansion of Human Capital /Conservation of the Global Environment / ESG Evaluation(16:25-

  3. Slide 3: Cautionary Notes

    Cautionary Notes Forecasts and other forward-looking statements included in this document are based on information currently available and certain assumptions that the Company deems reasonable. Actual performance and other results may differ significantly due to various factors. Such factors include

  4. Slide 4: Sustainable Management / Materiality

    Sustainable Management / Materiality / 44

  5. Slide 5: Sustainable Management Policy

    Sustainable Management Policy For more than 300 years since our founding, we have walked hand in hand with society. To help people who are suffering from disease, we have created a series of innovative new medicines that had been thought to be impossible. We will continue to contribute to people’s h

  6. Slide 6: Update Material Issues (Partial Revision)

    Update Material Issues(Partial Revision) STEP.1 STEP.2 STEP.3 STEP.4 Understanding of Issues Identify Material Issues Validation Review • Reflects changes in the external/internal environment and stakeholder’s voices • Reflect the business situation and the contents of the company's initiatives 「 Va

  7. Slide 7: Partial Revision of Material Issues (Content: Example)

    Partial Revision of Material Issues (Content:Example) 12 Assurance of Product 12 Assurance of Reliability and Safety Reliability and Safety Quality assurance and safety management of pharmaceutical Quality assurance and safety management of pharmaceutical Reason for products are fundamental to our b

  8. Slide 8: Update of Material Issues (Partial Revision)

    Update of Material Issues(Partial Revision) Current Material Issues Partially revise the title of Material Issues Currently:Assurance of Product Reliability and Safety Assurance of Reliability and 12 Safety Currently :Protection of Environment Conservation 14 of the global environment Currently :Tho

  9. Slide 9: New Material Issues (Overview)

    New Material Issues (Overview) Assurance of reliability and 12 safety 13 Stable Supply of Products Conservation of the global 14 environment 15 Respect for Human Rights 16 Thorough Compliance コンプライアンスの徹底 Realization of Sustainability 17 Management with Business Partners 8 / 45

  10. Slide 10: Creation of Innovative Drugs

    Materiality Issue 1 Creation of Innovative Drugs Management of priority issue The creation of innovative drugs is the practice of our corporate philosophy, “Dedicated to the Fight against Reason for being a Disease and Pain,” and is the core value we provide to society. To sustainably create this va

  11. Slide 11: Pipeline Expansion

    Materiality Issue 2 Pipeline Expansion Management of priority issue Reason for Our pipeline is the source of our sustainable growth. We continue enriching our pipeline to constantly being a priority provide innovative drugs to patients. issue The speed and accuracy of establishing PoC* for new drug

  12. Slide 12: Corporate Governance

    Corporate Governance / 44

  13. Slide 13: Corporate Governance Structure

    Corporate Governance Structure 12 / 45

  14. Slide 14: Members of the Board of Directors/Audit & Supervisory Board Member

    Members of the Board of Directors/Audit & Supervisory Board Member Name Statas, Assignments or Important Concurrent holding of Positions Gyo Sagara President, Representative Director, and Chief Executive Officer Toshihiro Member of the Board of Directors, Senior Executive Officer/ Executive Director

  15. Slide 15: Initiative for Corporate Governance

    Strengthening of Corporate Governance Initiative for Corporate Governance Material Issue 18 The executive appointment and executive compensation, both of which have governance-related importance are discussed at the meetings composed of highly independent Outside Board Director as key members in ord

  16. Slide 16: Initiative for Corporate Governance

    Strengthening of Corporate Governance Initiative for Corporate Governance Material Issue 18 The executive appointment and executive compensation, both of which have governance-related importance are discussed at the meetings composed of highly independent Outside Board Director as key members in ord

  17. Slide 17: Involvement of outside directors

    Succession plan ~2022 Execution for selective training such as executive training programs Jan. 2023 Confirmed to start specific discussions to select successor of the president Involvement of outside directors Jul. 2023 Narrowing down candidates Interview with candidates only by outside director -

  18. Slide 18: Expansion of Human Capital / Conservation of the Global Environment / ESG Evaluation

    Expansion of Human Capital / Conservation of the Global Environment / ESG Evaluation 17 / 44

  19. Slide 19: Expansion of Human Capital

    Expansion of Human Capital 18 / 44

  20. Slide 20: Partial Revision of Material Issues "Expansion of Human Capital"

    Partial Revision of Material Issues "Expansion of Human Capital" 8 Expansion of human capital Vision Vision We provide talent development programs to selected people, Based on the human resource strategy for the realization of the corporate approximately 30% of employees of our group companies, and

  21. Slide 21: Human Resources Strategy for Expansion of Human Capital

    Human Resources Strategy for Expansion of Material Issue 8 Human Capital Professional Talent Versatile Talent 20 / 45

  22. Slide 22: 1. A Pool of Talent for All Growth Strategies

    1. A Pool of Talent for All Growth Strategies Material Issue 8  In the “A pool of talent for all growth strategies," the status of versatile and professional talent is followed.  Initiatives and progress are described later. Category KPI item KPI figure A pool of talent for Recruiting and training

  23. Slide 23: Next generation executive talent

    1. Development the Versatile Talent who Support the Management Foundation ① Material Issue 8 -Training of Next generation executive talent ・Global talent - Next generation executive talent Object Development of next-generation management candidates Talent capable of serving as next- Talent capable o

  24. Slide 24: Management Foundation ②

    1. Development the Versatile Talent who Support the Management Foundation ② Material Issue 8 -Digital talent development training - Understanding DX DX participation DX lead Definition With the participated DX project DX project Able to understand DX Active Able to plan, manage, and execute Digital

  25. Slide 25: Management Foundation ③

    1. Development the Versatile Talent who Support the Management Foundation ③ Material Issue 8 - Development of innovative talent (Ono Innovation Platform) -  Talent development program aimed at accelerating the challenges of each and every employee  Supporting employees so that they can discover wh

  26. Slide 26: 1. A Pool of Talent for All Growth Strategies

    1. A Pool of Talent for All Growth Strategies Material Issue 8 - Development Status of Cross-Sectional Talent -  Ensure that cross-functional talent are developed through various trainings, etc.  In the future, we will maximize the use of Workday, the new talent management system, to promote effic

  27. Slide 27: 1. A Pool of Talent for All Growth Strategies

    1. A Pool of Talent for All Growth Strategies Material Issue 8 - Goal of hiring and developing specialists: About 700 in the next 5 years -  For specialized talent, the organization of talent needs was completed in FY 2022 (approximately - 700 people)  From this fiscal year, we will start hiring e

  28. Slide 28: 2. Enhancement of Talent Capabilities

    2. Enhancement of Talent Capabilities Material Issue 8  We are advancing initiatives aimed at the development of all employees' capabilities through talent development activities.  Initiatives and progress are described later. Category KPI item KPI figure A pool of talent for Recruiting and traini

  29. Slide 29: 2. Enhancement of Talent Capabilities

    2. Enhancement of Talent Capabilities Material Issue 8 - Building a rich training lineup -  Conducted workshops for all employees to disseminate the Mission Statement, along with tiered training and support for self-education  Hold trainings for effective operation of personnel measures such as ra

  30. Slide 30: Enhancement of Talent Capabilities

    2. Enhancement of Talent Capabilities Material Issue 8 - Training outcomes, etc. (FY 2022 preliminary report) -  Behavioral change rate after receiving training and the number of hours of training per person met the target or exceeded the level of the last year  There is room for further improveme

  31. Slide 31: 3. Working to Foster an Organizational Culture with High Employee Engagement

    3. Working to Foster an Organizational Culture with High Material Issue 8 Employee Engagement  In "Fostering an organizational culture with high employee engagement", we are following up on the progress of creating a system to ensure that the talents we have hired and developed can work with peace

  32. Slide 32: Landscape of Employee Engagement (FY 2022)

    Landscape of Employee Engagement (FY 2022) Material Issue 8  The Ono Pharmaceutical Group's overall employee engagement (68) is: High level compared to domestic benchmark (58) (slightly lower than global benchmark (all industries) (76))  Aim to achieve an engagement score higher than the Global Be

  33. Slide 33: 3. Fostering an Organizational Culture with High Employee Engagement

    3. Fostering an Organizational Culture with High Employee Material Issue 8 Engagement  Aim to improve engagement by providing systems and measures to attract talent and enhancing the sense of unity among the group (emphasis on the balance between career autonomy and organizational commitment)  Est

  34. Slide 34: Diversification of Managers

    Diversification of Managers Material Issue 8  In diversification of managers, efforts are being made with a focus on improving the ratio of female managers Management, etc. (attribute)  Gender(biological)2024.01  Employment form 2024.01 Employee Percentage of Employee Percentage of manger manger

  35. Slide 35: Development Program for Diversifying Experiences and Perspective of Individuals

    Development Program for Diversifying Experiences and Material Issue 8 Perspective of Individuals ⇒ Expansion of the Open Recruiting System To promote employee career development and enhance vitality and competitiveness through talent exchange Solicit job offers from each department and realize trans

  36. Slide 36: Individual Diversity Development Program 2

    Individual Diversity Development Program 2: Material issue 8 ⇒ Introduction an Internal Challenge Job System • Those who want to try a different role but are concerned about suitability • Those who are not thinking about moving to another department right now but want to broaden their perspectives b

  37. Slide 37: Toward Diversifying Workstyles

    Toward Diversifying Workstyles Material Issue 8 ① Changed the operation of working from home and introduced of the Super Flex system (May 2023) To foster a sense of unity and allow diverse working styles at the same time, telecommuting rules will be Set by Each Division, in principle. Optimal work s

  38. Slide 38: Landscape of Employee Engagement (FY 2023)

    Landscape of Employee Engagement (FY 2023) Material Issue 8  Employee engagement across the group is high compared to the benchmark for all domestic industries (Slightly behind Global BM)  Compared to the previous survey, the positive response rate tended to increase slightly (+1), but “I am excit

  39. Slide 39: Promotion of Health and Productivity Management

    Promotion of Health and Productivity Management Material Issue 8 Our company KPIs Fisical Year 2018 2019 2020 2021 2022 2026 Difference between actual UP age and healthy age ▲1.4 ▲1.5 ▲1.4 ▲1.8 ▲1.8 ▲3.0 Our company's Health Challenges Examples of Actions to Solve Issues Psychiatric Distribution of

  40. Slide 40: Conservation of the Global Environment

    Conservation of the Global Environment 39 / 44

  41. Slide 41: Partial Revision of Material Issues "Conservation of the Global Environment"

    Partial Revision of Material Issues “Conservation of the Global Environment" 14 Protection of the Global Environment 14 Conservation of the Global Environment Major initiatives Major initiatives Realization of a decarbonized society Reduce greenhouse gas emissions and increase • Reduce energy consu

  42. Slide 42: Conservation of the Global Environment

    Protecting Value Conservation of the Global Environment Material Issue 14 Recognizing that our business activities benefit from the environment and aiming to realize a sustainable and affluent society, we have adopted the environmental vision, “ECO VISION 2050” and are striving to resolve environmen

  43. Slide 43: Conservation of the Global Environment

    Protecting Value Conservation of the Global Environment Material Issue 14 Medium- to long-term environmental Targets 42 / 45

  44. Slide 44: Roadmap for Achieving a Decarbonized Society

    Protecting Value Conservation of the Global Environment Material Issue 14 Roadmap for Achieving a Decarbonized Society 43 / 45

  45. Slide 45: Biodiversity Conservation Initiatives

    Protecting Value Conservation of the Global Environment Material Issue 14 Biodiversity Conservation Initiatives We are grasping the risks and opportunities related to biodiversity in our company's management in accordance with the LEAP approach, and at the same time, we are making preparations for i

  46. Slide 46: External ESG Evaluation

    External ESG Evaluation Evaluation institution FY 2021 FY 2022 FY 2023 79/100 points 79/100 points 77/100 points DJSI World Index World Index World Index Selected Selected Selected FTSE 4.2 points/5 points 4.3 points/5 points 4.5 points/5 points Selected Selected Selected ESG MSCI Score: A Score: AA

  47. Slide 47: Dedicated to the Fight against Disease and Pain

    Dedicated to the Fight against Disease and Pain

Ono Pharmaceutical — ESG Presentation (March 2024) on 6ix